about
Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trialsChronic hepatitis C: This and the new era of treatmentEffect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic miceTargeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence.Molecular Bases Underlying the Hepatoprotective Effects of Coffee.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature.The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms.Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies.Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.Non-Alcoholic Steatohepatitis: Pathogenesis and Clinical ManagementEffects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas.Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.Silibinin Restores NAD⁺ Levels and Induces the SIRT1/AMPK Pathway in Non-Alcoholic Fatty Liver.Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis.Hepatitis C virus eradication by direct antiviral agents improves glucose tolerance and reduces post-load insulin resistance in nondiabetic patients with genotype 1.Efficacy of adipose tissue-mesenchymal stem cell transplantation in rats with acetaminophen liver injury.Protective role of soluble receptor for advanced glycation end-products in patients with non-alcoholic fatty liver disease.Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease.Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.Simple Scores of Fibrosis and Mortality in Patients with NAFLD: A Systematic Review with Meta-AnalysisCorrigendum to “Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis” [Dig. Liver Dis. 44 (2012) 334–342]Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axisEndoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectivesDietary vitamin E and C intake is inversely associated with the severity of nonalcoholic fatty liver diseaseHigh Intake of Phenolic Acid Is Associated With Reduced Risk of Colorectal Adenomas Among Smokers
P50
Q26748608-FE4BAB65-3757-48F7-9A0D-6BCF9B268711Q26775011-D64B4615-EBEA-4E60-876E-4C18E3AAA212Q35153847-B073D1B5-C9BA-4BA2-A67A-0F445BA7A327Q35759448-8B73C8B6-D4C8-4C1F-98EE-4BC102FAD56AQ37628490-121DD847-B447-4863-8B34-B80116629794Q38599131-A32C5B26-6EAD-4AD2-8F95-275F6ED7B1E0Q38802527-27B743A0-BED5-4617-89F2-212AAF19DB47Q38975832-83CB8CDA-A1B1-4E92-87D9-02DC7CE00748Q39216518-0026866A-DBD1-4675-9248-C6C9B7CDBF13Q40068043-BE9A96C8-2A25-4AAD-B281-B68A83D6B19BQ41734184-7FED6664-0EC8-466A-A1E7-743AF20265C8Q42247086-B6AD093C-CB3C-4FAF-A066-F4D845C62E29Q42987060-B35113DC-BA00-4406-9202-17606BE0CA4DQ43036848-E0DDD5B8-9916-4C7D-994B-1ED64613F25AQ45408801-6F5F0687-6021-4B85-AA28-0CDDB5525B57Q45531739-AEAEA48F-3BF4-48D3-AA9F-AEB9FFBE8038Q46861795-6F023B98-D741-4055-92AA-6FCB35186630Q47562255-9AF68889-50B1-468A-B563-907DB80AF01DQ47757173-D3699029-8ECD-4563-A7D6-BA972AB69A97Q51272711-56BD4EA4-1E80-4D48-AAA4-17E66C9CD202Q53813254-27D55612-2100-45B4-832B-FB42B33A212EQ54402713-C1D3F753-F40E-481C-80CC-773D425A2FCBQ54540861-B6BA2068-C778-42B1-940D-C9A4B783CED5Q58776930-C6477DAE-D25B-42E8-A9FA-A3B4C2B4D1B0Q61756897-6ECE3057-E967-491B-A5A7-46C65BCD94F0Q64099181-7356E9E3-1C6E-4DB6-8DBA-09B27DEE2594Q90386254-D687933F-D752-4F57-8E7E-1DE48467A6CEQ91686083-BE141EBF-63C3-4EE8-8F24-4BBDD3B3C5B8Q93036543-2B54A809-8444-4D99-827E-EFF651EBE498
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federico Salomone
@ast
Federico Salomone
@en
Federico Salomone
@es
Federico Salomone
@sl
type
label
Federico Salomone
@ast
Federico Salomone
@en
Federico Salomone
@es
Federico Salomone
@sl
altLabel
Federico Salamone
@en
prefLabel
Federico Salomone
@ast
Federico Salomone
@en
Federico Salomone
@es
Federico Salomone
@sl
P1053
R-6598-2016
P106
P1153
56544586800
P21
P2798
P31
P3829
P496
0000-0001-5264-2935